Antibiotic PCD Pharma Franchise Company — Why Quality Matters Here More Than Anywhere Else
India’s antibiotic market is large and growing, valued at roughly USD 3.1 billion in 2025 and expected to approach USD 4.7 billion by 2034. But this category carries a weight that most other therapeutic segments don’t: India also has one of the highest antimicrobial resistance rates in the world, with recent global surveillance findings suggesting […]
